不同传代数的永生化人脑微血管内皮细胞的功能评估:体外血脑屏障模型变异性管理前瞻性建议的案例研究

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Seiya Ohki , Mei Fukuda , Tomoyo Baba , Naomi Wakayama , Hanae Morio , Shingo Ito , Sumio Ohtsuki , Yoshiyuki Yamaura , Takafumi Komori , Tomomi Furihata
{"title":"不同传代数的永生化人脑微血管内皮细胞的功能评估:体外血脑屏障模型变异性管理前瞻性建议的案例研究","authors":"Seiya Ohki ,&nbsp;Mei Fukuda ,&nbsp;Tomoyo Baba ,&nbsp;Naomi Wakayama ,&nbsp;Hanae Morio ,&nbsp;Shingo Ito ,&nbsp;Sumio Ohtsuki ,&nbsp;Yoshiyuki Yamaura ,&nbsp;Takafumi Komori ,&nbsp;Tomomi Furihata","doi":"10.1016/j.dmpk.2025.101058","DOIUrl":null,"url":null,"abstract":"<div><div><em>In vitro</em> blood-brain barrier (BBB) models, primarily consisting of brain microvascular endothelial cells (BMEC), are expected to play pivotal roles in evaluating drug permeability into the brain. However, these models often exhibit functional variability due to various factors, raising practical concerns that can hinder their use in drug development studies. By investigating cell passage numbers as one such factor, we aim to assess how BBB model functionality is affected and to propose a practical strategy for managing this variability. In transwell-BBB models - but not in spheroidal-BBB models - the intercellular barrier integrity was somewhat compromised when higher-passage human immortalized BMEC (HBMEC/ci18) were used. Nonetheless, a clear <em>in vitro-in vivo</em> correlation (IVIVC) curve could still be obtained with these transwell-BBB models, similar to those with lower passage number HBMEC/ci18, presumably allowing for reasonable estimation of <em>in vivo</em> drug permeability. Therefore, changes in functional levels of BBB models do not always significantly diminish their practical value in drug BBB permeability studies. Additionally, the IVIVC curve integrity may serve as an indicator for assessing acceptable BBB model functionality. These findings provide valuable insights for the future application of <em>in vitro</em> human BBB models in drug development studies.</div></div>","PeriodicalId":11298,"journal":{"name":"Drug Metabolism and Pharmacokinetics","volume":"62 ","pages":"Article 101058"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Functional assessment of immortalized human brain microvascular endothelial cells with different passage numbers: A case study for a prospective proposal on variability management of in vitro blood-brain barrier models\",\"authors\":\"Seiya Ohki ,&nbsp;Mei Fukuda ,&nbsp;Tomoyo Baba ,&nbsp;Naomi Wakayama ,&nbsp;Hanae Morio ,&nbsp;Shingo Ito ,&nbsp;Sumio Ohtsuki ,&nbsp;Yoshiyuki Yamaura ,&nbsp;Takafumi Komori ,&nbsp;Tomomi Furihata\",\"doi\":\"10.1016/j.dmpk.2025.101058\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>In vitro</em> blood-brain barrier (BBB) models, primarily consisting of brain microvascular endothelial cells (BMEC), are expected to play pivotal roles in evaluating drug permeability into the brain. However, these models often exhibit functional variability due to various factors, raising practical concerns that can hinder their use in drug development studies. By investigating cell passage numbers as one such factor, we aim to assess how BBB model functionality is affected and to propose a practical strategy for managing this variability. In transwell-BBB models - but not in spheroidal-BBB models - the intercellular barrier integrity was somewhat compromised when higher-passage human immortalized BMEC (HBMEC/ci18) were used. Nonetheless, a clear <em>in vitro-in vivo</em> correlation (IVIVC) curve could still be obtained with these transwell-BBB models, similar to those with lower passage number HBMEC/ci18, presumably allowing for reasonable estimation of <em>in vivo</em> drug permeability. Therefore, changes in functional levels of BBB models do not always significantly diminish their practical value in drug BBB permeability studies. Additionally, the IVIVC curve integrity may serve as an indicator for assessing acceptable BBB model functionality. These findings provide valuable insights for the future application of <em>in vitro</em> human BBB models in drug development studies.</div></div>\",\"PeriodicalId\":11298,\"journal\":{\"name\":\"Drug Metabolism and Pharmacokinetics\",\"volume\":\"62 \",\"pages\":\"Article 101058\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Metabolism and Pharmacokinetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1347436725000084\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Pharmacokinetics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1347436725000084","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

体外血脑屏障(BBB)模型主要由脑微血管内皮细胞(BMEC)组成,有望在评估药物进入大脑的通透性方面发挥关键作用。然而,由于各种因素,这些模型往往表现出功能的可变性,这引起了实际问题,可能阻碍它们在药物开发研究中的应用。通过研究细胞传代数作为一个这样的因素,我们的目标是评估BBB模型功能是如何受到影响的,并提出一个实用的策略来管理这种可变性。在transwell-BBB模型中,使用高传代人永生化BMEC (HBMEC/ci18)时,细胞间屏障的完整性有所损害,但在球形bbb模型中没有。尽管如此,这些transwell-BBB模型仍然可以获得清晰的体外-体内相关(IVIVC)曲线,类似于传代数HBMEC/ci18较低的模型,可能可以合理估计体内药物通透性。因此,血脑屏障模型功能水平的变化并不总是显著降低其在药物血脑屏障通透性研究中的实用价值。此外,IVIVC曲线完整性可以作为评估可接受的BBB模型功能的指标。这些发现为未来体外血脑屏障模型在药物开发研究中的应用提供了有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Functional assessment of immortalized human brain microvascular endothelial cells with different passage numbers: A case study for a prospective proposal on variability management of in vitro blood-brain barrier models
In vitro blood-brain barrier (BBB) models, primarily consisting of brain microvascular endothelial cells (BMEC), are expected to play pivotal roles in evaluating drug permeability into the brain. However, these models often exhibit functional variability due to various factors, raising practical concerns that can hinder their use in drug development studies. By investigating cell passage numbers as one such factor, we aim to assess how BBB model functionality is affected and to propose a practical strategy for managing this variability. In transwell-BBB models - but not in spheroidal-BBB models - the intercellular barrier integrity was somewhat compromised when higher-passage human immortalized BMEC (HBMEC/ci18) were used. Nonetheless, a clear in vitro-in vivo correlation (IVIVC) curve could still be obtained with these transwell-BBB models, similar to those with lower passage number HBMEC/ci18, presumably allowing for reasonable estimation of in vivo drug permeability. Therefore, changes in functional levels of BBB models do not always significantly diminish their practical value in drug BBB permeability studies. Additionally, the IVIVC curve integrity may serve as an indicator for assessing acceptable BBB model functionality. These findings provide valuable insights for the future application of in vitro human BBB models in drug development studies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
9.50%
发文量
50
审稿时长
69 days
期刊介绍: DMPK publishes original and innovative scientific papers that address topics broadly related to xenobiotics. The term xenobiotic includes medicinal as well as environmental and agricultural chemicals and macromolecules. The journal is organized into sections as follows: - Drug metabolism / Biotransformation - Pharmacokinetics and pharmacodynamics - Toxicokinetics and toxicodynamics - Drug-drug interaction / Drug-food interaction - Mechanism of drug absorption and disposition (including transporter) - Drug delivery system - Clinical pharmacy and pharmacology - Analytical method - Factors affecting drug metabolism and transport - Expression of genes for drug-metabolizing enzymes and transporters - Pharmacogenetics and pharmacogenomics - Pharmacoepidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信